Clever Leaves Holdings, Inc. (CLVR)
Market Cap | 235.16M |
Revenue (ttm) | 11.39M |
Net Income (ttm) | n/a |
Shares Out | 15.11M |
EPS (ttm) | n/a |
PE Ratio | n/a |
Forward PE | n/a |
Dividend | n/a |
Dividend Yield | n/a |
Trading Day | January 26 |
Last Price | $9.29 |
Previous Close | $9.33 |
Change ($) | -0.04 |
Change (%) | -0.43% |
Day's Open | 9.50 |
Day's Range | 9.10 - 9.93 |
Day's Volume | 1,141,050 |
52-Week Range | 8.74 - 13.00 |
Clever Leaves is a cannabis company that has one of the lowest costs of production in an industry that is rapidly commoditizing. Since its SPAC, Clever Leaves has the best financial metrics in...
SPAC week continues with Kyle Detwiler, CEO of Clever Leaves, a recent entrant to Nasdaq. Building one of the largest cannabis companies in the world using a much more capital efficient fundin...
SPAC week continues with Kyle Detwiler, CEO of Clever Leaves, a recent entrant to Nasdaq. Building one of the largest cannabis companies in the world using a much more capital efficient fundin...
Clever Leaves to Receive US$11.4 Million Over Three-year Deal Clever Leaves to Receive US$11.4 Million Over Three-year Deal
It's no secret that small caps offer the potential for greater returns for those who can recognize companies trading at discounts to their intrinsic values. But many small-caps are unknown, le...
NEW YORK, Jan. 06, 2021 (GLOBE NEWSWIRE) -- Clever Leaves Holdings Inc. (NASDAQ: CLVR) (“Clever Leaves” or the “Company”), a leading multi-national operator and licensed producer of pharmaceut...
NEW YORK, Dec. 21, 2020 (GLOBE NEWSWIRE) -- Clever Leaves Holdings Inc. (NASDAQ: CLVR, CLVRW) (“Clever Leaves” or the “Company”), a leading multi-national operator and licensed producer of pha...
CLVR stock will start trading on the Nasdaq today after Clever Leaves completed its SPAC merger with Schultze Special Purpose Acquisition. The post CLVR Stock: 12 Things to Know as Cannabis Pl...
Common Shares and Warrants of the Combined Company to Begin Trading on Nasdaq Under Symbols CLVR and CLVRW on Friday, December 18, 2020 Common Shares and Warrants of the Combined Company to Be...
SPACs have been one of the hottest investment stories of 2020. The blank check, reverse merger vehicles have taken numerous private companies — as well as former public companies — public on m...
The improving regulatory landscape for marijuana stocks could usher in a boom, particularly for companies focused on the U.S. market. The post 7 Marijuana Stocks Hoping 2021 Brings Federal Leg...
Former U.S. Senate Majority Leader, Tom Daschle Will Also Discuss Cannabis Regulation and Legislation Former U.S. Senate Majority Leader, Tom Daschle Will Also Discuss Cannabis Regulation and ...
Companies to Host Joint Investor Webinar and Q&A Session Today at 11:00 AM ET Companies to Host Joint Investor Webinar and Q&A Session Today at 11:00 AM ET
RYE BROOK, N.Y., Sept. 28, 2020 (GLOBE NEWSWIRE) -- Schultze Special Purpose Acquisition Corp. (Nasdaq: SAMA, SAMAW and SAMAU) (the “Company”) today announced that it intends to convene and ...
RYE BROOK, N.Y., Sept. 24, 2020 (GLOBE NEWSWIRE) -- Schultze Special Purpose Acquisition Corp. (NASDAQ: SAMA, SAMAW, and SAMAU) (“SAMA”) and Clever Leaves International Inc. (“Clever Leaves”...
Electrameccanica Vehicles’ flagship vehicle, the SOLO, is interesting. Yet SOLO stock wouldn’t be my first choice for $170 million.
Presentation and Q&A Session Scheduled for Thursday, September 10 at 11:00 AM EDT Presentation and Q&A Session Scheduled for Thursday, September 10 at 11:00 AM EDT
These SPACs have already found companies to complete reverse mergers with. Look for the SPAC stocks to double or even triple in the next year.
RYE BROOK, N.Y., Aug. 07, 2020 (GLOBE NEWSWIRE) -- Schultze Special Purpose Acquisition Corp. (NASDAQ: SAMA, SAMAW, and SAMAU) (“SAMA”) announced today that Clever Leaves Holdings Inc. (“Hol...
Schultze Special Purpose Acquisition Corp. (NASDAQ: SAMA) made a notable move on Monday.
About CLVR
Clever Leaves Holdings cultivates, produces, and sells pharmaceutical-grade cannabinoids. It invests and operates in Colombia, Portugal, Germany, the United States, and Canada. The company was founded in 2018 and is based in New York, New York.
Industry Drug Manufacturers-Specialty & Generic | Founded 2016 |
CEO Kyle Detwiler | |
Stock Exchange NASDAQ | Ticker Symbol CLVR |